With JFS Care’s Independence Program, David now sees a caregiver 16 hours a month, the staff at JFS Care call him 4 times a week to check in, JFS Care arranges LYFT rides to get him to his activities, he has a Phillips Lifeline at home, and his JFS Care Case Manager comes to visit him each month.
Rita, a self taught gourmet chef, loves to cook for her family when they come visit, and she even hosts dinner for 10 every month. Rita can’t see as well as she used to, but with the help of JFS Care’s in-home services, she can still create wonderful meals for her loved ones.
At first I thought of accepting help as losing our independence, but now I realize, it’s allowed us to keep it. Our JFS Personal Care Assistant helps us accomplish the things we want to do each day.
I live in New York, I try to get to Los Angeles as often as I can, it is hard being so far away.
I’m grateful to JFS Care for treating my father like he is a member of their own family. I know he is safe and happy.
As my illness progressed so did my needs, this placed strain on my marriage and my family life. We reached out to JFS Care and now I and my family have the vital support we needed. I have the help I need each day and my family has the respite they deserve.
Get exclusive information about senior care in the Los Angeles area. Subscribe to our blog.
Caring for a loved one with dementia is obviously nothing to laugh about. Yet scientific studies are increasingly pointing to the advantages of humor, and incorporating it into dementia care could possibly be just what the doctor ordered to boost overall wellbeing for your loved one.
Continue reading
Of the many responsibilities a family caregiver faces, perhaps one of the more daunting is managing health conditions. The National Council on Aging reports that nearly ¾ of all older adults are clinically determined to have a minimum of two chronic illnesses, and are seeing an average of four senior care physicians.
Continue reading
After 16 long years without any truly viable treatment options for Alzheimer’s, there is some optimism on the horizon in a stunning reversal on the formerly-rejected antibody therapy, aducanumab. The newest research reveals that large quantities of the medication do, in fact, decrease cognitive decline at the beginning stages of Alzheimer’s.
Continue reading
